AAAAAA
Results: 1-25/80
Authors:
Ferrari, R
Ryden, L
Citation: R. Ferrari et L. Ryden, Hypertrophic cardiomyopathy: from molecular and genetic mechanisms to clinical management, EUR H J SUP, 3(L), 2001, pp. L1-L2
Authors:
Ryden, L
Gadler, F
Citation: L. Ryden et F. Gadler, Pharmacological therapy for hypertrophic cardiomyopathy: what is the evidence for success?, EUR H J SUP, 3(L), 2001, pp. L21-L25
Authors:
Ferrari, R
Ryden, L
Citation: R. Ferrari et L. Ryden, Myocardial ischaemia and reperfusion injury: from experimental evidence toclinical practice - Introduction, EUR H J SUP, 3(C), 2001, pp. C1-C1
Authors:
Ryden, L
Sjoquist, PO
Wang, WD
Citation: L. Ryden et al., Pharmacological tools for the limitation of myocardial reperfusion injury - Experimental evidence, EUR H J SUP, 3(C), 2001, pp. C28-C35
Authors:
Ryden, L
Simoons, ML
Bassand, JP
Citation: L. Ryden et al., Partnership in cardiovascular medicine - A key to success not only for professional organizations, EUR HEART J, 22(20), 2001, pp. 1839-1843
Authors:
Frykman, V
Beerman, B
Ryden, L
Rosenqvist, M
Citation: V. Frykman et al., Management of atrial fibrillation: discrepancy between guideline recommendations and actual practice exposes patients to risk for complications, EUR HEART J, 22(20), 2001, pp. 1954-1959
Authors:
Cleland, JGF
Thygesen, K
Uretsky, BF
Armstrong, P
Horowitz, JD
Massie, B
Packer, M
Poole-Wilson, PA
Ryden, L
Citation: Jgf. Cleland et al., Cardiovascular critical event pathways for the progression of heart failure - A report from the ATLAS study, EUR HEART J, 22(17), 2001, pp. 1601-1612
Authors:
Ohlsson, A
Kubo, SH
Steinhaus, D
Connelly, DT
Adler, S
Bitkover, C
Nordlander, R
Ryden, L
Bennett, T
Citation: A. Ohlsson et al., Continuous ambulatory monitoring of absolute right ventricular pressure and mixed venous oxygen saturation in patients with heart failure using an implantable haemodynamic monitor - Results of a 1 year multicentre feasibility study, EUR HEART J, 22(11), 2001, pp. 942-954
Authors:
Alpert, JS
Thygesen, K
Antman, E
Bassand, JP
Apple, F
Armstrong, PW
Bassand, JP
de Luna, AB
Beller, G
Breithardt, G
Chaitman, BR
Clemmensen, P
Falk, E
Fishbein, MC
Galvani, M
Garson, A
Grines, C
Hamm, C
Hoppe, U
Jaffe, A
Katus, H
Kjekshus, J
Klein, W
Klootwijk, P
Lenfant, C
Levy, D
Levy, RI
Luepker, R
Marcus, F
Naslund, U
Ohman, M
Pahlm, O
Poole-Wilson, P
Popp, R
Pyorala, J
Ravkilde, J
Rehnquist, N
Roberts, W
Roberts, R
Roelandt, J
Ryden, L
Sans, S
Simoons, ML
Thygesen, K
Tunstall-Pedoe, H
Underwood, R
Uretsky, BF
Van de Werf, F
Voipio-Pulkki, LM
Wagner, G
Wallentin, L
Wijns, W
Wood, D
Sendon, JLL
Tendera, M
Citation: Js. Alpert et al., Myocardial infarction redefined - A consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction (Reprinted from J Am Coll Cardiol, vol36, pg 959-69, 2000), CLIN CHEM, 47(3), 2001, pp. 382-392
Authors:
Massie, BM
Armstrong, PW
Cleland, JGF
Horowitz, JD
Packer, M
Poole-Wilson, PA
Ryden, L
Citation: Bm. Massie et al., Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure - Results from the ATLAS trial, ARCH IN MED, 161(2), 2001, pp. 165-171
Authors:
Ryden, L
Malmberg, K
Citation: L. Ryden et K. Malmberg, Benefits of ACE inhibitors: what remains to be proven?, EUR H J SUP, 2(I), 2000, pp. L3-L7
Authors:
Braunschweig, F
Linde, C
Gadler, F
Ryden, L
Citation: F. Braunschweig et al., Reduction of hospital days by biventricular pacing, EUR J HE FA, 2(4), 2000, pp. 399-406
Authors:
Sculpher, MJ
Poole, L
Cleland, J
Drummond, M
Armstrong, PW
Horowitz, JD
Massie, BM
Poole-Wilson, PA
Ryden, L
Citation: Mj. Sculpher et al., Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) study, EUR J HE FA, 2(4), 2000, pp. 447-454
Authors:
Ryden, L
Citation: L. Ryden, Renin-angiotensin system modulating treatments in the management of cardiovascular disease, HEART, 84, 2000, pp. I1-I1
Authors:
Ryden, L
Citation: L. Ryden, Managing cardiovascular risk in patients with diabetes, HEART, 84, 2000, pp. I23-I25
Authors:
Al-Khalili, F
Svane, B
Di Mario, C
Prati, F
Mallus, MT
Ryden, L
Schenck-Gustafsson, K
Citation: F. Al-khalili et al., Intracoronary ultrasound measurements in women with myocardial infarction without significant coronary lesions, CORON ART D, 11(8), 2000, pp. 579-584
Authors:
Beller, GA
Ryden, L
Citation: Ga. Beller et L. Ryden, Joint efforts across national boundaries between professional organizations in cardiovascular medicine: One way into the future, J AM COL C, 36(3), 2000, pp. 957-958
Authors:
Alpert, JS
Antman, E
Apple, F
Armstrong, PW
Bassand, JP
de Luna, AB
Beller, G
Breithardt, G
Chaitman, BR
Clemmensen, P
Falk, E
Fishbein, MC
Galvani, M
Garson, A
Grines, C
Hamm, C
Jaffe, A
Katus, H
Kjekshus, J
Klein, W
Klootwijk, P
Lenfant, C
Levy, D
Levy, RI
Luepker, R
Marcus, F
Naslund, U
Ohman, M
Pahlm, O
Poole-Wilson, P
Popp, R
Alto, P
Pyorala, K
Ravkilde, J
Rehnquist, N
Roberts, W
Roberts, R
Roelandt, J
Ryden, L
Sans, S
Simoons, ML
Thygesen, K
Tunstall-Pedoe, H
Underwood, R
Uretsky, BF
Van de Werf, F
Voipio-Pulkki, LM
Wagner, G
Wallentin, L
Wijns, W
Wood, D
Citation: Js. Alpert et al., Myocardial infarction redefined - A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction, J AM COL C, 36(3), 2000, pp. 959-969
Authors:
von Bibra, H
Bone, D
Voigt, JU
Niklasson, U
Wranne, B
Ryden, L
Citation: H. Von Bibra et al., Contrast echocardiography, Z KARDIOL, 89, 2000, pp. 86-96
Authors:
Almbrand, B
Johannesson, M
Sjostrand, B
Malmberg, K
Ryden, L
Citation: B. Almbrand et al., Cost-effectiveness of intense insulin treatment after acute myocardial infarction in patients with diabetes mellitus - Results from the DIGAMI study, EUR HEART J, 21(9), 2000, pp. 733-739
Authors:
Oto, A
Ryden, L
Citation: A. Oto et L. Ryden, Continuing medical education in cardiology: the ESC perspective, EUR HEART J, 21(3), 2000, pp. 182-184
Authors:
Ryden, L
Armstrong, PW
Cleland, JFG
Horowitz, JD
Massie, BM
Packer, M
Poole-Wilson, PA
Citation: L. Ryden et al., Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus - Results from the ATLAS trial, EUR HEART J, 21(23), 2000, pp. 1967-1978
Authors:
Beller, GA
Ryden, L
Citation: Ga. Beller et L. Ryden, Joint efforts across national boundaries between professional organizations in cardiovascular medicine: one way into the future, EUR HEART J, 21(18), 2000, pp. 1492-1493
Authors:
Alpert, JS
Antman, E
Apple, F
Armstrong, PW
Bassand, JP
de Luna, AB
Beller, G
Breithardt, G
Chaitman, BR
Clemmensen, P
Falk, E
Fishbein, MC
Galvani, M
Garson, A
Grines, C
Hamm, C
Hoppe, U
Jaffe, A
Katus, H
Kjekshus, J
Klein, W
Klootwijk, P
Lenfant, C
Levy, D
Levy, RI
Luepker, R
Marcus, F
Naslund, U
Ohman, M
Pahlm, O
Poole-Wilson, P
Popp, R
Pyorala, K
Ravkilde, J
Rehnquist, N
Roberts, W
Roberts, R
Roelandt, J
Ryden, L
Sans, S
Simoons, ML
Thygesen, K
Tunstall-Pedoe, H
Underwood, R
Uretsky, BF
de Werf, FV
Voipio-Pulkki, LM
Wagner, G
Wallentin, L
Wijns, W
Wood, D
Citation: Js. Alpert et al., Myocardial infarction redefined - A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction, EUR HEART J, 21(18), 2000, pp. 1502-1513
Authors:
Ryden, L
Simoons, ML
Citation: L. Ryden et Ml. Simoons, The European Society of Cardiology into the next decade, EUR HEART J, 21(15), 2000, pp. 1193-1201